Special national collection of insulin: Ganli pharmaceutical Ganjing and asparagus insulin all reported the lowest prices: 48.71 yuan and 19.98 yuan

Beyond Capital: Why Europe Needs Industrial Partners, Not Just Investors

Europe’s reindustrialization is creating new opportunities for Chinese companies. However, the winners will not necessarily be those seeking quick acquisitions or rapid market access. The real opportunities belong to companies capable of embedding themselves into Europe’s industrial ecosystem and supporting the long-term transformation of local industries.

EHang and Sri Lanka Explore Regulatory Path for Pilotless eVTOL Services

EHang Holdings (亿航智能) and Sri Lanka’s Civil Aviation Authority have held technical discussions on the possible introduction of electric vertical take-off and landing aircraft, or eVTOLs, into the country’s aviation system.

Kanghong’s Conbercept Receives Marketing Authorization in Guyana

Kanghong Pharmaceutical (康弘药业) said its subsidiary Kanghong Bioscience had received a drug registration certificate from Guyana’s Food and Drug Department for conbercept ophthalmic injection, marketed under the brand name Lumitin (朗沐).

Perfect World’s NTE Tops RMB2 Billion in Global Gross Billings

Perfect World Games (完美世界游戏) said its self-developed open-world action RPG Neverness to Everness (NTE, 《异环》) had generated more than RMB2 billion in cumulative global gross billings as of Aug. 18, according to the company’s 2026 interim report.

LimX Dynamics Reportedly Files Confidential Hong Kong IPO as Overseas Orders Exceed Half of Total

LimX Dynamics (逐际动力), a Shenzhen-based embodied-AI robotics company, has reportedly submitted a confidential application for a Hong Kong initial public offering and is considering a fundraising of up to US$300 million, according to a Caixin report published on Aug. 20.